Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Jason Skinner got tested for hepatitis C and then got into care and treatment. Those two simple decisions changed his life.
Nearly a third of teens and young adults improperly use tranquilizers, stimulants and other psychoactive drugs.
The death rate spiked right after the COVID-19 pandemic began.
Areas with lower population density have not seen the same slowdown as urban areas.
Researchers found that longer usage of injection drugs was positively linked to hep C testing.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
A series of lawsuits have charged that chains like CVS, Rite Aid and Walgreens share blame for opioid overprescribing.
Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.
Federal judge rules in favor of nonprofit seeking to open the country’s first overdose prevention facility.
That sliver of physicians was also more inclined to prescribe doses of opioids higher and for longer than what the CDC recommends.
An analysis of nearly 8,000 heart transplants found that whether or not the donor had hepatitis C, 90% of recipients survived one year.
A recent survey found that pharmacies are insufficiently educating the public about unused opioid and antibiotic disposal.
Researchers believe that lack of economic opportunity drives an increase in opioid use among local residents.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
Taking opioids at the same time as benzodiazepines, such as Xanax and Ativan, is also associated with overdose.
The majority of new cases of hepatitis C occur among people younger than 30 who inject drugs.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.